Sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists treatment: variable observations of sequelae on diabetic retinopathy
Affiliation
University Hospitals of North Midlands NHS Trust; University Hospitals Birmingham NHS Foundation TrustPublication date
2023-12-06
Metadata
Show full item recordAbstract
No abstract available.Citation
Varughese GI, Jacob S. Sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists treatment: variable observations of sequelae on diabetic retinopathy. J R Soc Med. 2023 Dec;116(12):408. doi: 10.1177/01410768231215999. Epub 2023 Dec 6.Type
CorrespondenceAdditional Links
https://journals.sagepub.com/home/jrsPMID
38054392Publisher
SAGE Publicationsae974a485f413a2113503eed53cd6c53
10.1177/01410768231215999